These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 10222599

  • 1. Flavobacterium meningosepticum bacteremia: an analysis of 16 cases.
    Liu CE, Wong WW, Yang SP, Wang FD, Fung CP, You KW, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Mar; 62(3):125-32. PubMed ID: 10222599
    [Abstract] [Full Text] [Related]

  • 2. [Elizabethkingia meningosepticum bacteremia in a patient with Bardet-Biedl syndrome and chronic renal failure].
    Bayrak B, Fıncanci M, Bınay UD, Çımen C, Özkantar Ünlügüneş GU.
    Mikrobiyol Bul; 2014 Jul; 48(3):495-500. PubMed ID: 25052117
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.
    Chang JC, Hsueh PR, Wu JJ, Ho SW, Hsieh WC, Luh KT.
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1301-6. PubMed ID: 9174188
    [Abstract] [Full Text] [Related]

  • 4. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review.
    Bloch KC, Nadarajah R, Jacobs R.
    Medicine (Baltimore); 1997 Jan; 76(1):30-41. PubMed ID: 9064486
    [Abstract] [Full Text] [Related]

  • 5. In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options.
    Di Pentima MC, Mason EO, Kaplan SL.
    Clin Infect Dis; 1998 May; 26(5):1169-76. PubMed ID: 9597247
    [Abstract] [Full Text] [Related]

  • 6. Flavobacterium spp. organisms as opportunistic bacterial pathogens during advanced HIV disease.
    Manfredi R, Nanetti A, Ferri M, Mastroianni A, Coronado OV, Chiodo F.
    J Infect; 1999 Sep; 39(2):146-52. PubMed ID: 10609533
    [Abstract] [Full Text] [Related]

  • 7. Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia.
    Lin PY, Chen HL, Huang CT, Su LH, Chiu CH.
    Int J Antimicrob Agents; 2010 Nov; 36(5):436-40. PubMed ID: 20933186
    [Abstract] [Full Text] [Related]

  • 8. Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin B.
    Brown RB, Phillips D, Barker MJ, Pieczarka R, Sands M, Teres D.
    Am J Infect Control; 1989 Jun; 17(3):121-5. PubMed ID: 2545119
    [Abstract] [Full Text] [Related]

  • 9. Flavobacterium meningosepticum sepsis: disease due to bacteria with unusual antibiotic susceptibility.
    Harrington SP, Perlino CA.
    South Med J; 1981 Jun; 74(6):764-6. PubMed ID: 7244763
    [Abstract] [Full Text] [Related]

  • 10. Flavobacterium meningosepticum.
    Ratner H.
    Infect Control; 1984 May; 5(5):237-9. PubMed ID: 6563023
    [Abstract] [Full Text] [Related]

  • 11. Relapse of catheter-related Flavobacterium meningosepticum bacteremia demonstrated by DNA macrorestriction analysis.
    Sader HS, Jones RN, Pfaller MA.
    Clin Infect Dis; 1995 Oct; 21(4):997-1000. PubMed ID: 8645856
    [Abstract] [Full Text] [Related]

  • 12. [Clinical and bacteriological study on Flavobacterium meningosepticum (author's transl)].
    Igari J, Kosakai N, Oguri T.
    Jpn J Antibiot; 1977 Mar; 30(3):242-9. PubMed ID: 857060
    [Abstract] [Full Text] [Related]

  • 13. Brevundimonas vesicularis bacteremia resistant to trimethoprim-sulfamethoxazole and ceftazidime in a tertiary hospital in southern Taiwan.
    Zhang CC, Hsu HJ, Li CM.
    J Microbiol Immunol Infect; 2012 Dec; 45(6):448-52. PubMed ID: 22516745
    [Abstract] [Full Text] [Related]

  • 14. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit.
    Chou DW, Wu SL, Lee CT, Tai FT, Yu WL.
    Jpn J Infect Dis; 2011 Dec; 64(6):520-4. PubMed ID: 22116334
    [Abstract] [Full Text] [Related]

  • 15. Capnocytophaga bacteremia: clinical features of patients and antimicrobial susceptibility of isolates.
    Lin RD, Hsueh PR, Chang SC, Luh KT.
    J Formos Med Assoc; 1998 Jan; 97(1):44-8. PubMed ID: 9481064
    [Abstract] [Full Text] [Related]

  • 16. Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan.
    Chiu CH, Waddingdon M, Greenberg D, Schreckenberger PC, Carnahan AM.
    Emerg Infect Dis; 2000 Jan; 6(5):481-6. PubMed ID: 10998378
    [Abstract] [Full Text] [Related]

  • 17. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan.
    Lin YT, Chiu CH, Chan YJ, Lin ML, Yu KW, Wang FD, Liu CY.
    Scand J Infect Dis; 2009 Jan; 41(9):628-34. PubMed ID: 19579148
    [Abstract] [Full Text] [Related]

  • 18. Analysis of an outbreak due to Chryseobacterium meningosepticum in a neonatal intensive care unit.
    Tekerekoglu MS, Durmaz R, Ayan M, Cizmeci Z, Akinci A.
    New Microbiol; 2003 Jan; 26(1):57-63. PubMed ID: 12578312
    [Abstract] [Full Text] [Related]

  • 19. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes.
    Sligl W, Taylor G, Brindley PG.
    Int J Infect Dis; 2006 Jul; 10(4):320-5. PubMed ID: 16460982
    [Abstract] [Full Text] [Related]

  • 20. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics.
    Hsueh PR, Hsiue TR, Wu JJ, Teng LJ, Ho SW, Hsieh WC, Luh KT.
    Clin Infect Dis; 1996 Sep; 23(3):550-5. PubMed ID: 8879779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.